Cormica, a global leader in life sciences testing and consulting, has successfully acquired Zwisler Laboratorium, a premier laboratory services provider based in Reichenau, Germany. This acquisition marks a significant milestone for Cormica, as it represents the company’s first foray into the German market, a key component of its strategy to expand across Europe. With the acquisition, Cormica aims to strengthen its position in high-growth European markets and explore further expansion opportunities in Germany.
Founded in 2001, Zwisler Laboratorium is known for its advanced in-vitro testing services and its expertise in meeting rigorous regulatory standards for pharmaceutical, biotech, medical device, and packaging industries across Europe. The laboratory specializes in services like pyrogen testing, environmental monitoring, reprocessing validation, and microbiological integrity tests. By integrating Zwisler’s cutting-edge technologies and expertise into its portfolio, Cormica enhances its ability to support life science manufacturers, helping them bring critical medical technologies to market quickly and safely. This acquisition complements Cormica's existing operations in the UK and US and positions the company for continued growth in the global life sciences testing market.
